NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹230 Cr | ₹102 Cr | ₹198 Cr | ₹161 Cr | ₹76 Cr |
What is the latest Contingent Liabilities ratio of NECTAR LIFESCIENCES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹230 Cr |
| Mar2025 | ₹102 Cr |
| Mar2024 | ₹198 Cr |
| Mar2023 | ₹161 Cr |
| Mar2022 | ₹76 Cr |
How is Contingent Liabilities of NECTAR LIFESCIENCES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹230 Cr | 125.14 | |
| Mar2025 | ₹102 Cr | -48.56 | |
| Mar2024 | ₹198 Cr | 22.75 | |
| Mar2023 | ₹161 Cr | 113.41 | |
| Mar2022 | ₹76 Cr | - | |
Compare Contingent Liabilities of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹208.5 Cr | 3.6% | 6.3% | -29.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,291.0 Cr | -1.8% | 7.6% | 11.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹305,014.0 Cr | 3.7% | 27.2% | 71.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,333.0 Cr | -2.3% | 1.5% | 23.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,017.0 Cr | 0.6% | 13.4% | 15.7% | Stock Analytics | |
| CIPLA | ₹112,539.0 Cr | -1.3% | 6.1% | -6.9% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | 3.6% |
6.3% |
-29.5% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses